仅供参考。不构成财务建议。
当前关键数据
翻译版分析（2026年4月18日）早于当前英文分析（2026年6月14日），因此不予显示。以下数据与英文页面来自同一数据源。 阅读最新英文分析
- 行业板块: 医疗保健
CNVCF 的竞争对手是谁？
下表将 CNVCF 与 8 家同行在价格、市值和我们的 AI MoonshotScore 上进行比较。
| 公司 | 价格 | 市值 | MoonshotScore |
|---|---|---|---|
| BGM BGM Group Ltd. | $8.40 | $100M | 47 |
| ORGO Organogenesis Holdings Inc. | $0.9354 | $126M | 37 |
| OGI Organigram Global Inc. | $0.939 | $132M | 35 |
| CRDL Cardiol Therapeutics Inc. | $1.12 | $135M | 52 |
| DERM Journey Medical Corporation | $4.97 | $142M | 33 |
| ZYBT Zhengye Biotechnology Holding Limited | $1.42 | $67.3M | 31 |
| CPIX Cumberland Pharmaceuticals Inc. | $4.35 | $65.2M | 35 |
| TLPH Talphera, Inc. | $1.07 | $55.5M | — |
AI 评分来自 Stock Expert AI · 价格数据：FMP / Yahoo Finance
最新新闻
-
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
benzinga · 312 天前
-
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
benzinga · 313 天前
-
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
benzinga · 447 天前
-
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
benzinga · 503 天前
数据仅供参考。